Extracorporeal shockwave lithotripsy (ESWL) is a promising non-surgical treatment for selected patients with cholecystolithiasis.' To achieve complete stone clearance, however, ESWL must be combined with adjuvant oral cholelitholysis by chenodeoxycholic or ursodeoxycholic acid, or both. Notwithstanding its simplicity and harmlessness, oral dissolution treatment is expensive and must be continued for at least six to 12 months after primary therapy by ESWL.' The use of dissolution solvents for direct percutaneous gall bladder perfusion may therefore afford a favourable alternative and is of renewed interest.
Mono-octanoin was found to be a useful substance for direct dissolution of retained cholesterol bile duct stones by either T tube infusion26 or by percutaneous transhepatic catheterisation.' It is also used through an endoscopically positioned nasobiliary catheter. 7 Rapid dissolution of cholesterol gall stones with methyl tert-butyl ether (MTBE) 16 More recently, the authors changed the prescription of the d-limonene preparation to 70% d-limonene and 30% middle chain monoglyceride to improve efficacy and reduce the side effects of the previous preparation. '7 In vitro studies showed extraordinary synergism when dlimonene and mono-octanoin were used in a 3:2 mixture to dissolve cholesterol stones. '5 In this study we compared the gall stone dissolving capacity of four different dissolution solvents in vitro: MTBE, mono-octanoin, a 97% limonene preparation and a limonene/monooctanoin mixture.
Methods

STONES
Nine sets of five gall stones were obtained from nine consecutive patients who underwent elective cholecystectomy for symptomatic gall bladder stones. By gross observation, the stones comprising one set were comparable in morphology and size, and assumed to be of similar chemical composition. The stones were stored at 4°C in phosphate buffered saline (PBS), containing 50000 IU/1 penicillin and 50 000 ,tg/A streptomycin. One stone from each set was used for chemical analysis ofcholesterol, calcium, and bilirubin contents, as described previously. 18 The remaining four stones were used to study dissolution by different solvents.
The 36 stones used for dissolution were placed on blotting paper and allowed to dry in air for one hour before weighing and measuring the maximum diameter of each stone. A Mettler PK 300 digital balance (Mettler Instrumente AG, Greifensee, Switzerland) was used for weighing. DISSOLUTION 
SOLVENTS
The following dissolving agents were used: mono-octanoin Vergunst, Terpstra, Nijs, Steen In each of the four solvents, the pigment stones (set 6) disintegrated partly or completely into multiple fragments. The weights of these stones were reduced by 20-35% within the first two to six hours; thereafter a further decrease in weight did not occur (Fig 1) .
The remaining cholesterol stones incubated in MTBE, mono-octanoin, limonene, and limonene/mono-octanoin had mean (range) weights of 845 (110-1634), 702 (132-1563), 787 (123-1854), and 787 (79-2046) mg respectively. The mean (range) diameters were 13-7 (6.5-20.5), 12.7 (6-8-19-1), 13-7 (6-8-21-0), and 12.8 (6-0-18. 1) mm respectively. For the four different solvents, the weights and diameters of the stones did not differ significantly.
During dissolution of the cholesterol stones in MTBE, limonene, and limonene/mono-octanoin most stones broke into multiple fragments; in mono-octanoin this occurred in two cases only. All cholesterol stones dissolved completely in either solvent, except one stone from set 9, which was reduced by only 50%. The stones from set 5, which had the highest percentage of cholesterol (Table I) , dissolved completely'without leaving any residue. Dissolution of the other stones resulted in a sand-like debris (except for stones from set 9). Figure 2 shows the results for the eight sets of cholesterol stones for each time point; data are expressed as the mean percentage of the initial stone weight. In MTBE, stones dissolved within two hours. In mono-octanoin, limonene, and limonene/mono-octanoin, however, ±85%, ±40%, and ±20% respectively were still left after 24 hours. Dissolution with mono-octanoin was completed after 10 days. In Table II the median 25% and 50% dissolving times are given. MTBE dissolved cholesterol gall stones 100 times faster than mono-octanoin (p<O-OOl) and 10 times faster than limonene or limonene/mono-octanoin (p<OOO1). The combination of limonene and mono-octanoin was as effective as limonene alone.
The four parameter logistic equation proved to be an adequate mathematical description for the weight reduction of the stones in either solvent. A typical example is shown in Figure 3 . Figure 4 illustrates the relative reduction in stone weight and the relative recovery of cholesterol from mono-octanoin, limonene, and limonene/mono-octanoin, expressed as a percentage of the initial stone weight. Data on MTBE are not available due to technical difficulties caused by the volatility of the solvent. The reduction in stone weight paralleled the recovery of cholesterol, showing that the reduction in stone weight was due to dissolution of cholesterol.
Discussion
The combination of chenodeoxycholic and In this study we compared four different solvents possibly suited for post ESWL contact dissolution. The cholesterol dissolving capacity of different limonene preparations versus MTBE and mono-octanoin, respectively, had not previously been compared in vitro.
We found that MTBE dissolved cholesterol stones in vitro more than 100 times faster than mono-octanoin. This finding corroborates the previously reported superior dissolving capacity of MTBE compared with mono-octanoin, even for stones with a cholesterol content of only 40%. 35 Compared with the limonene preparations MTBE dissolved comparable stones 10 times faster. It has been reported that pigment stones are not dissolved by MTBE.3536 The pigment stones in our study, however, were partly dissolved by either solvent. Since these stones did not contain any cholesterol, the weight reduction must be caused by dissolution of other organic constituents.
In conclusion, MTBE, which has been used clinically for dissolution of gall bladder stones without severe side effects or complications,8 is the most potent cholesterol solvent now available. Combining ESWL and contact dissolution therapy probably renders more patients with cholecystolithiasis eligible for non-surgical treatment. Of the 4 solvents, MTBE is the best one to evaluate for dissolution of residual fragments after ESWL.
